Laboratory Animal Welfare: Clarification of Position Statements on Implementation of the Eighth Edition of the Guide for the Care and Use of Laboratory Animals, 38073-38074 [2012-15596]

Download as PDF 38073 Federal Register / Vol. 77, No. 123 / Tuesday, June 26, 2012 / Notices (#0925–0552). Need and Use of Information Collection: The National Diabetes Education Program (NDEP) is a partnership of the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) and more than 200 public and private organizations. The longterm goal of the NDEP is to reduce the burden of diabetes and prediabetes in the United States, and its territories, by facilitating the adoption of proven strategies to prevent or delay the onset of diabetes and its complications. The NDEP objectives are to: (1) Increase awareness and knowledge of the seriousness of diabetes, its risk factors, and effective strategies for preventing type 2 diabetes and complications associated with diabetes; (2) increase the number of people who live well with diabetes and effectively manage their disease to prevent or delay complications and improve quality of life; (3) decrease the number of Americans with undiagnosed diabetes; (4) Among people at risk for type 2 diabetes, increase the number who make and sustain effective lifestyle changes to prevent diabetes; (5) facilitate efforts to improve diabetes-related health care and education, as well as systems for delivering care; (6) reduce health disparities in populations disproportionately burdened by diabetes; and (7) facilitate the incorporation of evidence-based research findings into health care practices. Multiple strategies have been devised to address the NDEP objectives. These have been described in the NDEP Strategic Plan and include: (1) Promoting and implementing culturally and linguistically-appropriate diabetes awareness and education campaigns for a wide variety of audiences; (2) identifying, disseminating, and supporting the adoption of evidencebased, culturally and linguisticallyappropriate tools and resources that support behavior change, improved quality of life, and better diabetes outcomes; (3) expanding NDEP reach and visibility through collaborations with public, private, and nontraditional partners, and use of national, state, and local media, traditional and social media, and other relevant channels; and (4) conducting and supporting the evaluation of NDEP resources, promotions, and other activities to improve future NDEP initiatives. The NDEP evaluation will document the extent to which the NDEP program has been implemented, and how successful it has been in meeting program objectives. The evaluation relies heavily on data gathered from existing national surveys such as National Health and Nutrition Examination Survey (NHANES), the National Health Interview Survey (NHIS), and the Behavioral Risk Factor Surveillance System (BRFSS), among others for this information. This generic clearance request is for the collection of additional primary data from NDEP target audiences on key impact measures that are necessary to effectively evaluate the program. Approval is requested for a survey of audiences targeted by the National Diabetes Education Program including people at risk for diabetes and people with diabetes and their families and the public. Frequency of Response: One occasion. Affected Public: Individuals or households. Type of Respondents: Adults. The annual reporting burden is as follows: Estimated Number of Respondents: 3759; Estimated Number of Responses per Respondent: 1; Average Burden Hours per Response: .153; and Estimated Total Annual Burden Hours Requested: 575. There are no Capital Costs, Operating or Maintenance Costs to report. ESTIMATES OF HOUR BURDEN Number of respondents Type of respondents Frequency of response Average time per response Total hour burden 1,659 2,100 1 1 .03 .25 50 525 Totals ........................................................................................................ rmajette on DSK2TPTVN1PROD with NOTICES Screening interview with ineligible persons ..................................................... Eligible respondents ........................................................................................ 3,759 ........................ ........................ 575 Request for Comments: Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Evaluate whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Evaluate the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. VerDate Mar<15>2010 15:33 Jun 25, 2012 Jkt 226001 Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Regulatory Affairs, OIRA_submission@omb.eop.gov or by fax to 202–395–6974, Attention, Desk Officer for NIH. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact Joanne Gallivan, M.S., R.D., Director, National Diabetes Education Program, NIDDK, NIH, Building 31, Room 9A06, 31 Center Drive, Bethesda, MD 20892, or call non-toll-free number (301) 494– 6110 or Email your request, including your address to: Joanne_Gallivan@nih.gov. Comments Due Date: Comments regarding this information collection are PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 best assured of having their full effect if received within 30 days of the date of this publication. Dated: April 20, 2012. Camille Hoover, Executive Officer, NIDDK. [FR Doc. 2012–15594 Filed 6–25–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Laboratory Animal Welfare: Clarification of Position Statements on Implementation of the Eighth Edition of the Guide for the Care and Use of Laboratory Animals AGENCY: National Institutes of Health, HHS. E:\FR\FM\26JNN1.SGM 26JNN1 38074 ACTION: Federal Register / Vol. 77, No. 123 / Tuesday, June 26, 2012 / Notices Notice. The National Institutes of Health (NIH) is providing clarification after analyzing public comments received regarding the 10 Position Statements that were developed to aid research institutions in their implementation of the 8th Edition of the Guide for the Care and Use of Laboratory Animals (Guide). In response to those comments, NIH has clarified Position Statements (1) Cost, (2) Housing, (2a) Nonhuman Primate Housing, (2c) Rodent Housing, and (3) Non-Pharmaceutical-Grade Substances. FOR FURTHER INFORMATION CONTACT: Office of Laboratory Animal Welfare, Office of Extramural Research, NIH, RKL1, Suite 360, 6705 Rockledge Drive, Bethesda, MD 20892–7982; phone 301– 496–7163. SUPPLEMENTARY INFORMATION: rmajette on DSK2TPTVN1PROD with NOTICES SUMMARY: I. Background Since 1985, the Public Health Service (PHS) Policy on Humane Care and Use of Laboratory Animals, authorized by Public Law 99–158, 42 U.S.C. 289d, and incorporated by reference at 42 CFR 52.8 and 42 CFR 52a.8, has required that institutions receiving PHS support for animal activities base their animal care and use programs on the current edition of the Guide. The 8th Edition of the Guide was published in January 2011 by the National Research Council of the National Academy of Sciences. (See https://www.nap.edu/ catalog.php?record_id=12910.) Following a public comment period, NIH adopted the 8th Edition of the Guide in December 2011 and released 10 Position Statements to aid PHSAssured institutions—those with an approved Animal Welfare Assurance— in their implementation of the Guide (76 FR 74803). The public was invited to submit comments on their understanding of the Position Statements until February 3, 2012 (76 FR 74804, https://grants.nih.gov/grants/ guide/notice-files/NOT-OD-12042.html). NIH received a total of 44 comments: 26 responses from those who identified themselves as individuals, 6 from PHS-Assured institutions, 2 from animal advocacy organizations, and 9 from professional organizations. The comments may be viewed at https:// grants.nih.gov/grants/olaw/2011position statement_comments/web_listing.htm. In response to those comments, NIH has clarified the following Position Statements: (1) Cost, (2) Housing, (2a) Nonhuman Primate Housing, (2c) Rodent Housing, and (3) NonPharmaceutical-Grade Substances. (See https://grants.nih.gov/grants/olaw/ VerDate Mar<15>2010 15:33 Jun 25, 2012 Jkt 226001 positionstatement_guide.htm.) For a summary of the changes in the Position Statements, see https://grants.nih.gov/ grants/olaw/2011positionstatement_ maysummary.pdf (PDF). For an archive of the original version, see https:// grants.nih.gov/grants/olaw/2011position statement_decarchive.pdf (PDF). II. Electronic Access The 8th Edition of the Guide is available on the NIH Office of Laboratory Animal Welfare Web site at https://olaw.nih.gov. Dated: June 19, 2012. Francis S. Collins, Director, National Institutes of Health. [FR Doc. 2012–15596 Filed 6–25–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Hematology. Date: July 16, 2012. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW., Washington, DC 20015. Contact Person: Bukhtiar H. Shah, DVM, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4120, MSC 7802, Bethesda, MD 20892, 301–806– 7314, shahb@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Hematology. Date: July 16, 2012. Time: 5:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. PO 00000 Frm 00042 Fmt 4703 Sfmt 9990 Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW., Washington, DC 20015. Contact Person: Anshumali Chaudhari, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4124, MSC 7802, Bethesda, MD 20892, (301) 435– 1210, chaudhaa@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Biobehavioral Mechanisms of Emotion, Stress and Health. Date: July 18, 2012. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Mark Lindner, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3182, MSC 7770, Bethesda, MD 20892, 301–435– 0913, mark.lindner@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Digestive Sciences. Date: July 23, 2012. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW., Washington, DC 20015. Contact Person: Bonnie L. Burgess-Beusse, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2182, MSC 7818, Bethesda, MD 20892, 301–435– 1783, beusseb@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Program Project: MacCHESS. Date: July 23–25, 2012. Time: 7:00 p.m. to 11:00 a.m. Agenda: To review and evaluate grant applications. Place: Cornell University, Campus Information and Visitor Relations, Day Hall Lobby, Ithaca, NY 14853. Contact Person: Nitsa Rosenzweig, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1102, MSC 7760, Bethesda, MD 20892, (301) 435– 1747, rosenzweign@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: June 20, 2012. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2012–15593 Filed 6–25–12; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\26JNN1.SGM 26JNN1

Agencies

[Federal Register Volume 77, Number 123 (Tuesday, June 26, 2012)]
[Notices]
[Pages 38073-38074]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-15596]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Laboratory Animal Welfare: Clarification of Position Statements 
on Implementation of the Eighth Edition of the Guide for the Care and 
Use of Laboratory Animals

AGENCY: National Institutes of Health, HHS.

[[Page 38074]]


ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Institutes of Health (NIH) is providing 
clarification after analyzing public comments received regarding the 10 
Position Statements that were developed to aid research institutions in 
their implementation of the 8th Edition of the Guide for the Care and 
Use of Laboratory Animals (Guide). In response to those comments, NIH 
has clarified Position Statements (1) Cost, (2) Housing, (2a) Nonhuman 
Primate Housing, (2c) Rodent Housing, and (3) Non-Pharmaceutical-Grade 
Substances.

FOR FURTHER INFORMATION CONTACT: Office of Laboratory Animal Welfare, 
Office of Extramural Research, NIH, RKL1, Suite 360, 6705 Rockledge 
Drive, Bethesda, MD 20892-7982; phone 301-496-7163.

SUPPLEMENTARY INFORMATION: 

I. Background

    Since 1985, the Public Health Service (PHS) Policy on Humane Care 
and Use of Laboratory Animals, authorized by Public Law 99-158, 42 
U.S.C. 289d, and incorporated by reference at 42 CFR 52.8 and 42 CFR 
52a.8, has required that institutions receiving PHS support for animal 
activities base their animal care and use programs on the current 
edition of the Guide. The 8th Edition of the Guide was published in 
January 2011 by the National Research Council of the National Academy 
of Sciences. (See https://www.nap.edu/catalog.php?record_id=12910.) 
Following a public comment period, NIH adopted the 8th Edition of the 
Guide in December 2011 and released 10 Position Statements to aid PHS-
Assured institutions--those with an approved Animal Welfare Assurance--
in their implementation of the Guide (76 FR 74803). The public was 
invited to submit comments on their understanding of the Position 
Statements until February 3, 2012 (76 FR 74804, https://grants.nih.gov/grants/guide/notice-files/NOT-OD-12-042.html). NIH received a total of 
44 comments: 26 responses from those who identified themselves as 
individuals, 6 from PHS-Assured institutions, 2 from animal advocacy 
organizations, and 9 from professional organizations. The comments may 
be viewed at https://grants.nih.gov/grants/olaw/2011positionstatement_comments/web_listing.htm.
    In response to those comments, NIH has clarified the following 
Position Statements: (1) Cost, (2) Housing, (2a) Nonhuman Primate 
Housing, (2c) Rodent Housing, and (3) Non-Pharmaceutical-Grade 
Substances. (See https://grants.nih.gov/grants/olaw/positionstatement_guide.htm.) For a summary of the changes in the Position Statements, 
see https://grants.nih.gov/grants/olaw/2011positionstatement_maysummary.pdf (PDF). For an archive of the original version, see 
https://grants.nih.gov/grants/olaw/2011positionstatement_decarchive.pdf 
(PDF).

II. Electronic Access

    The 8th Edition of the Guide is available on the NIH Office of 
Laboratory Animal Welfare Web site at https://olaw.nih.gov.

    Dated: June 19, 2012.
Francis S. Collins,
Director, National Institutes of Health.
[FR Doc. 2012-15596 Filed 6-25-12; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.